{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:20:29Z","timestamp":1783430429977,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"vor","delay-in-days":1236,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/ki.2012.77","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T12:44:11Z","timestamp":1332938651000},"page":"100-105","source":"Crossref","is-referenced-by-count":40,"title":["Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients"],"prefix":"10.1016","volume":"82","author":[{"given":"Sunita","family":"Sardiwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gardham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2012.77_bb0010","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.77_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1525-139X.2007.00261.x","article-title":"Vascular calcification and disordered mineral metabolism in dialysis patients","volume":"20","author":"Kalpakian","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2012.77_bb0025","series-title":"United Kingdom Renal Association Clinical practice guidelines","year":"2007"},{"key":"10.1038\/ki.2012.77_bb0030","series-title":"Kidney Disease Improving Global Outcomes Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease related mineral and bone disorders (CKD-MBD)","year":"2008"},{"key":"10.1038\/ki.2012.77_bb0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.ki.5002800","article-title":"Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?","volume":"73","author":"Drueke","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0040","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2215\/CJN.09471209","article-title":"Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis","volume":"5","author":"Gardham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1038\/ki.2012.77_bb0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2215\/CJN.04440510","article-title":"How many measurements to make a decision?","volume":"5","author":"Houillier","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total vs. bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000189578","article-title":"Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology","volume":"75","author":"Fletcher","year":"1997","journal-title":"Nephron"},{"key":"10.1038\/ki.2012.77_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S8756-3282(00)00279-9","article-title":"Components of biological variation of biochemical markers of bone turnover in Paget\u2032s bone disease","volume":"26","author":"Alvarez","year":"2000","journal-title":"Bone"},{"key":"10.1038\/ki.2012.77_bb0070","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/00365519509110260","article-title":"Biological variation in bone-derived biochemical markers in serum","volume":"55","author":"Panteghini","year":"1995","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1038\/ki.2012.77_bb0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0009-9120(01)00273-9","article-title":"Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women","volume":"34","author":"Scariano","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1038\/ki.2012.77_bb0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2012.77_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1258\/000456307780945633","article-title":"Within-subject biological variation in disease: collated data and clinical consequences","volume":"44","author":"Ricos","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1038\/ki.2012.77_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1258\/000456303763046175","article-title":"Stability of parathyroid hormone ex vivo in haemodialysis patients","volume":"40","author":"Teal","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1038\/ki.2012.77_bb0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/clinchem.2009.136754","article-title":"Influence of blood sampling site on intact parathyroid hormone concentrations in hemodialysis patients","volume":"56","author":"Vulpio","year":"2010","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2012.77_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/000456307779596039","article-title":"Parathyroid hormone, kidney disease, evidence and guidelines","volume":"44","author":"Lamb","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1038\/ki.2012.77_bb0105","first-page":"3923","article-title":"Accumulation of a non-(1\u201384) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2012.77_bb0110","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2215\/CJN.01770408","article-title":"Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients","volume":"4","author":"Moore","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0115","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ndt\/gfq541","article-title":"Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients","volume":"26","author":"Drechsler","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2012.77_bb0120","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/ndt\/gfp260","article-title":"The association between parathyroid hormone and mortality in dialysis patients is modified by wasting","volume":"24","author":"Drechsler","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2012.77_bb0125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4684-7758-0_44","article-title":"Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH","volume":"103","author":"Ritz","year":"1978","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/ki.2012.77_bb0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1038\/ki.2012.77_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2010.08.037","article-title":"Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry","volume":"57","author":"Tangri","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.77_bb0145","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1590\/S1516-31801998000500002","article-title":"The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings","volume":"116","author":"Duarte","year":"1998","journal-title":"Sao Paulo Med J"},{"key":"10.1038\/ki.2012.77_bb0150","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5414\/CNP74091","article-title":"Serum alkaline phosphatase and mortality in hemodialysis patients","volume":"74","author":"Beddhu","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2012.77_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0165","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2012.77_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4158\/EP10339.OR","article-title":"The effect of Vitamin D therapy on bone turnover markers in postmenopausal women with osteoporosis and osteopenia","volume":"17","author":"Tanzy","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1038\/ki.2012.77_bb0175","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0180","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"Manghat","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2012.77_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2012.77_bb0190","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0195","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00774-004-0528-9","article-title":"The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients","volume":"22","author":"Iba","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.1038\/ki.2012.77_bb0200","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.ki.5000297","article-title":"Chemical and hormonal determinants of vascular calcification in vitro","volume":"69","author":"Lomashvili","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.77_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","article-title":"Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages","volume":"91","author":"Shioi","year":"2002","journal-title":"Circ Res"},{"key":"10.1038\/ki.2012.77_bb0210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients","volume":"4","author":"Shantouf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.77_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","article-title":"Adynamic bone disease: clinical and therapeutic implications","volume":"18","author":"Frazao","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2012.77_bb0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2012.77_bb0225","first-page":"731","article-title":"IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1)","volume":"21","author":"Tietz","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1038\/ki.2012.77_bb0230","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/clinchem\/32.8.1593a","article-title":"Reference intervals for alkaline phosphatase activity determined by the IFCC and AACC reference methods","volume":"32","author":"Tietz","year":"1986","journal-title":"Clin Chem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815554343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815554343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T09:28:27Z","timestamp":1641634107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815554343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0085253815554343"],"URL":"https:\/\/doi.org\/10.1038\/ki.2012.77","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}